These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26895076)

  • 41. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.
    Siger-Zajdel M; Selmaj KW
    J Neurol; 2005 Jul; 252(7):830-2. PubMed ID: 15772740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
    Lovera J; Ramos A; Devier D; Garrison V; Kovner B; Reza T; Koop D; Rooney W; Foundas A; Bourdette D
    J Neurol Sci; 2015 Nov; 358(1-2):46-52. PubMed ID: 26298797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total brain N-acetylaspartate: a new measure of disease load in MS.
    Gonen O; Catalaa I; Babb JS; Ge Y; Mannon LJ; Kolson DL; Grossman RI
    Neurology; 2000 Jan; 54(1):15-9. PubMed ID: 10636119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.
    Ercan E; Magro-Checa C; Valabregue R; Branzoli F; Wood ET; Steup-Beekman GM; Webb AG; Huizinga TW; van Buchem MA; Ronen I
    Brain; 2016 May; 139(Pt 5):1447-57. PubMed ID: 26969685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
    Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypo-metabolism of the rostral anterior cingulate cortex associated with working memory impairment in 18 cases of schizophrenia.
    Mazgaj R; Tal A; Goetz R; Lazar M; Rothman K; Messinger JW; Malaspina D; Gonen O
    Brain Imaging Behav; 2016 Mar; 10(1):115-23. PubMed ID: 25804309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
    Mostert JP; Sijens PE; Oudkerk M; De Keyser J
    Neurosci Lett; 2006 Jul; 402(1-2):22-4. PubMed ID: 16644118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
    Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
    Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence of neuronal injury outside the medial temporal lobe in temporal lobe epilepsy: N-acetylaspartate concentration reductions detected with multisection proton MR spectroscopic imaging--initial experience.
    Vermathen P; Laxer KD; Schuff N; Matson GB; Weiner MW
    Radiology; 2003 Jan; 226(1):195-202. PubMed ID: 12511690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
    Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
    Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-related metabolic changes in the upper brainstem tegmentum by MR spectroscopy.
    Moreno-Torres A; Pujol J; Soriano-Mas C; Deus J; Iranzo A; Santamaria J
    Neurobiol Aging; 2005 Jul; 26(7):1051-9. PubMed ID: 15748785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy.
    Li LM; Cendes F; Antel SB; Andermann F; Serles W; Dubeau F; Olivier A; Arnold DL
    Ann Neurol; 2000 Feb; 47(2):195-200. PubMed ID: 10665490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
    Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
    BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study.
    Zick SM; Zwickey H; Wood L; Foerster B; Khabir T; Wright B; Ichesco E; Sen A; Harris RE
    Brain Imaging Behav; 2014 Dec; 8(4):506-16. PubMed ID: 24222427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing Fatigue-Related White Matter Changes in MS: A Proton Magnetic Resonance Spectroscopy Study.
    Yarraguntla K; Bao F; Lichtman-Mikol S; Razmjou S; Santiago-Martinez C; Seraji-Bozorgzad N; Sriwastava S; Bernitsas E
    Brain Sci; 2019 May; 9(5):. PubMed ID: 31137831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain metabolite alterations in children with primary nocturnal enuresis using proton magnetic resonance spectroscopy.
    Zhang J; Lei D; Ma J; Wang M; Shen G; Wang H; Yang G; Du X
    Neurochem Res; 2014 Jul; 39(7):1355-62. PubMed ID: 24792733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Changes in
    Meknatkhah S; Dashti PS; Raminfard S; Rad HS; Mousavi MS; Riazi GH
    J Mol Neurosci; 2021 Apr; 71(4):804-809. PubMed ID: 32915417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a.
    MacMillan EL; Schubert JJ; Vavasour IM; Tam R; Rauscher A; Taylor C; White R; Garren H; Clayton D; Levesque V; Li DK; Kolind SH; Traboulsee AL
    Mult Scler J Exp Transl Clin; 2019; 5(4):2055217319879952. PubMed ID: 31662881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.